Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RICARDO FERNANDEZ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1609913532
CMS profile
892798
Location
UPPER MARLBORO, MD

General Payments · PY2018–2024

$26,045.85

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,983.46

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $128.86 3
PY2019 $29.60 2
PY2021 $109.81 5
PY2022 $11,814.86 9
PY2023 $7,979.26 16
PY2024 $5,983.46 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.33 06/04/2024 Food and Beverage Undisputed 01/23/2026 1104677609 CMS
Bayer Healthcare Pharmaceuticals Inc. $39.50 04/21/2024 Food and Beverage Undisputed 01/23/2026 1086261934 CMS
Bayer Healthcare Pharmaceuticals Inc. $2,625.00 04/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086213329 CMS
Bayer Healthcare Pharmaceuticals Inc. $120.65 09/20/2024 Food and Beverage Undisputed 01/23/2026 1086114388 CMS
Bayer Healthcare Pharmaceuticals Inc. $2,888.00 09/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086234886 CMS
Exact Sciences Corporation $29.94 05/24/2024 Food and Beverage Undisputed 01/23/2026 1114656222 CMS
Exact Sciences Corporation $31.88 12/18/2024 Food and Beverage Undisputed 01/23/2026 1114656228 CMS
Gilead Sciences, Inc. $22.17 04/05/2024 Food and Beverage Undisputed 01/23/2026 1133756339 CMS
Merck Sharp & Dohme LLC $20.46 01/23/2024 Food and Beverage Undisputed 01/23/2026 1141730376 CMS
SANOFI PASTEUR INC. $18.10 03/20/2024 Food and Beverage Undisputed 01/23/2026 1128741604 CMS
ViiV Healthcare Company $24.04 01/12/2024 Food and Beverage Undisputed 01/23/2026 1112793496 CMS
ViiV Healthcare Company $15.15 02/13/2024 Food and Beverage Undisputed 01/23/2026 1112732295 CMS
ViiV Healthcare Company $104.00 02/28/2024 Food and Beverage Undisputed 01/23/2026 1112797362 CMS
ViiV Healthcare Company $21.24 03/23/2024 Food and Beverage Undisputed 01/23/2026 1112786254 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.